✦ LIBER ✦

Association of disease-free survival and percent of ideal dose in adjuvant breast chemotherapy

✍ Scribed by Nancy L. Geller; Thomas B. Hakes; Gina R. Petroni; Violante Currie; Richard Kaufman

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 674 KB
Volume: 66
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19901015)66:8<1678::aid-cncr2820660804>3.0.co;2-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of timing of initiation of adjuva

Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancer

✍ Aman U. Buzdar; Terry L. Smith; Kimberly C. Powell; George R. Blumenschein; Edmu 📂 Article 📅 1982 🏛 Springer US 🌐 English ⚖ 565 KB

Operable breast cancer: Influence of dis

Operable breast cancer: Influence of disease-free and overall survival by adjuvant chemotherapy (CMF) and postoperative radiotherapy (RT)

✍ R. Zucali; A. Rossi; P. Valagussa; G. Bonadonna 📂 Article 📅 1978 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Reduced recurrence-free survival after r

Reduced recurrence-free survival after reduced doses of adjuvant chemotherapy in breast cancer: Are groups selected after randomization comparable?

✍ Lars Erik Rutqvist; Arne Wallgren; Ann-Charlotte Wennerholm 📂 Article 📅 1986 🏛 Springer US 🌐 English ⚖ 199 KB

Disease-free survival at intervals durin

Disease-free survival at intervals during and following completion of adjuvant chemotherapy: The NSABP experience from three breast cancer protocols

✍ Bernard Fisher; Carol Redmond; Norman Wolmark; H. Samuel Wieand 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 605 KB

Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) trials evaluating three different regimens of adjuvant chemotherapy (L-PAM, L-PAM + 5-FU, L-PAM + 5-FU + MTX) in patients with primary breast cancer and positive axillary nodes indicate that each regimen has significantly

The effect of prior adjuvant chemotherap

The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer

✍ Frederick R. Ahmann; Stephen E. Jones; Thomas E. Moon 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 550 KB

Some adjuvantly treated patients develop recurrent breast cancer and little is known about the effect of prior adjuvant chemotherapy on subsequent response rates to systemic therapy or on overall survival. We describe our retrospective comparison of 179 patients who received doxorubicin containing a

Progesterone receptor activity and relap

Progesterone receptor activity and relapse-free survival in patients with primary breast cancer: The role of adjuvant chemotherapy

✍ J. M. M. Raemaekers; L. V. A. M. Beex; G. F. F. M. Pieters; A. G. H. Smals; Th. 📂 Article 📅 1987 🏛 Springer US 🌐 English ⚖ 806 KB